The three largest U.S. drug distributors, facing their first trial over claims that they fueled the opioid crisis, said responsibility for ballooning painkiller sales lies with doctors, drugmakers and regulators.
If you are not happy with the results below please do another search
50 search results for:
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc. and German partner BioNTech SE’s Covid-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on May 3, citing federal officials familiar with the regulatory agency’s plans.
New cases of Covid-19 in the United States fell for a third week in a row, dropping 15 percent during the week ended May 2 to 347,000 – the lowest weekly total since October – according to a Reuters analysis of state and county data.
One year after Astellas and California-based Cytokinetics extended an agreement to develop Skeletal Sarcomere Activators, the Japanese pharma company is walking away from the deal.
The U.S. Food and Drug Administration approved Chiesi Global Rare Diseases’ Ferriprox (deferiprone) for the treatment of transfusional iron overload caused by sickle cell disease or other anemias in adults and children ages 3 years and older.
India postponed exams for trainee doctors and nurses on May 3, freeing them up to fight the world’s biggest surge in coronavirus infections, as the health system crumbles under the weight of new cases and hospitals run out of beds and oxygen.
Roivant Sciences is combining with Montes Archimedes Acquisition Corp (MAAC), a particular purpose acquisition company sponsored by Patient Square Capital.
The U.S. Food and Drug Administration greenlit AstraZeneca’s Farxiga (dapagliflozin) under priority review for the treatment of chronic kidney disease in patients at risk of progression with or without type 2 diabetes.
Passage Bio Inc. and InformedDNA announced a collaboration to provide no-cost genetic counseling and testing for adults who have been diagnosed by their physicians with Frontotemporal Dementia (FTD).
More than 60 U.S. stadiums and other venues are deploying an app from Clear to verify people’s Covid-19 status, placing the New York company known for its airport security fast lanes at the forefront of a national debate over “vaccine passports.”